4//SEC Filing
Interpace Diagnostics Group, Inc. 4
Accession 0001192482-17-000079
$IDXGCIK 0001054102operating
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:08 PM ET
Size
5.7 KB
Accession
0001192482-17-000079
Insider Transaction Report
Form 4
Early James
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2017-03-16+14,475→ 14,475 totalExercise: $2.12Exp: 2027-03-16→ Common Stock (14,475 underlying)
Footnotes (1)
- [F1]The option award vests and becomes exercisable over a one-year period, commencing on March 16, 2017, in twelve equal installments, on the 15th day of each calendar month, subject to the reporting person's continued service with the issuer.
Documents
Issuer
Interpace Diagnostics Group, Inc.
CIK 0001054102
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001054102
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 4:08 PM ET
- Size
- 5.7 KB